化疗敏感-话题@MedSci

#化疗敏感#

14篇内容 | 1123人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2028883, encodeId=2165202888385, content=<a href='/topic/show?id=b2bd33559be' target=_blank style='color:#2F92EE;'>#化疗敏感#</a>, objectTitle=Mol Cancer：新型生物标志物SNORD33可预测三阴性乳腺癌对铂类化疗敏感性, objectType=article, longId=300796, objectId=4279300e9651, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4279300e9651, replyNumber=0, likeNumber=0, createdTime=2022-09-12, rootId=0, userName=ms9651749636653578, userId=47102500004, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4279300e9651, moduleTitle=Mol Cancer：新型生物标志物SNORD33可预测三阴性乳腺癌对铂类化疗敏感性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4279300e9651)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2028882, encodeId=e0e1202888272, content=<a href='/topic/show?id=b2bd33559be' target=_blank style='color:#2F92EE;'>#化疗敏感#</a>, objectTitle=Eur Urol：局部晚期和转移性尿道癌中成纤维细胞生长因子受体3的变异状态与对铂化疗敏感性的差异相关, objectType=article, longId=199985, objectId=72b119998516, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=72b119998516, replyNumber=0, likeNumber=95, createdTime=2020-12-08, rootId=0, userName=ms9651749636653578, userId=47102500004, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=72b119998516, moduleTitle=Eur Urol：局部晚期和转移性尿道癌中成纤维细胞生长因子受体3的变异状态与对铂化疗敏感性的差异相关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=72b119998516)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2028881, encodeId=1d2420288816e, content=<a href='/topic/show?id=b2bd33559be' target=_blank style='color:#2F92EE;'>#化疗敏感#</a>, objectTitle=Blood：IKAROS和CK2调控高危型B-ALL的BCL-XL表达和化疗敏感性, objectType=article, longId=195267, objectId=dea919526ed5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dea919526ed5, replyNumber=0, likeNumber=95, createdTime=2020-09-30, rootId=0, userName=ms9651749636653578, userId=47102500004, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dea919526ed5, moduleTitle=Blood：IKAROS和CK2调控高危型B-ALL的BCL-XL表达和化疗敏感性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dea919526ed5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2028880, encodeId=925a20288800f, content=<a href='/topic/show?id=b2bd33559be' target=_blank style='color:#2F92EE;'>#化疗敏感#</a>, objectTitle=Cell Death Dis：NOD2靶向调节AMPK通路抑制肝癌进展并提高其化疗敏感性, objectType=article, longId=190456, objectId=c01f190456e0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c01f190456e0, replyNumber=0, likeNumber=103, createdTime=2020-06-11, rootId=0, userName=ms9651749636653578, userId=47102500004, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c01f190456e0, moduleTitle=Cell Death Dis：NOD2靶向调节AMPK通路抑制肝癌进展并提高其化疗敏感性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c01f190456e0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2028879, encodeId=ff1020288e9e5, content=<a href='/topic/show?id=b2bd33559be' target=_blank style='color:#2F92EE;'>#化疗敏感#</a>, objectTitle=FDA接受葛兰素史克的补充新药申请，将其PARP抑制剂Zejula用作对铂类化疗敏感、晚期卵巢癌患者的一线维持治疗, objectType=article, longId=188795, objectId=27b9188e9585, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=27b9188e9585, replyNumber=0, likeNumber=85, createdTime=2020-12-01, rootId=0, userName=ms9651749636653578, userId=47102500004, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=27b9188e9585, moduleTitle=FDA接受葛兰素史克的补充新药申请，将其PARP抑制剂Zejula用作对铂类化疗敏感、晚期卵巢癌患者的一线维持治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=27b9188e9585)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2028878, encodeId=d3c620288e8ce, content=<a href='/topic/show?id=b2bd33559be' target=_blank style='color:#2F92EE;'>#化疗敏感#</a>, objectTitle=Prostate：CD4+ T浸润能够减弱前列腺癌的化疗敏感性, objectType=article, longId=166156, objectId=f6e516615677, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f6e516615677, replyNumber=0, likeNumber=74, createdTime=2019-06-20, rootId=0, userName=ms9651749636653578, userId=47102500004, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f6e516615677, moduleTitle=Prostate：CD4+ T浸润能够减弱前列腺癌的化疗敏感性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f6e516615677)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2028877, encodeId=be3720288e7ee, content=<a href='/topic/show?id=b2bd33559be' target=_blank style='color:#2F92EE;'>#化疗敏感#</a>, objectTitle=BJC：达沙替尼靶向乳腺癌干细胞增加三阴性乳腺癌化疗敏感性, objectType=article, longId=154827, objectId=019c15482e73, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=019c15482e73, replyNumber=0, likeNumber=87, createdTime=2019-04-02, rootId=0, userName=ms9651749636653578, userId=47102500004, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=019c15482e73, moduleTitle=BJC：达沙替尼靶向乳腺癌干细胞增加三阴性乳腺癌化疗敏感性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=019c15482e73)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2028876, encodeId=77eb20288e69c, content=<a href='/topic/show?id=b2bd33559be' target=_blank style='color:#2F92EE;'>#化疗敏感#</a>, objectTitle=LANCET ONCOL：胃癌术后辅助化疗敏感患者的鉴别, objectType=article, longId=133319, objectId=c5ea1333190f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c5ea1333190f, replyNumber=0, likeNumber=135, createdTime=2018-04-14, rootId=0, userName=ms9651749636653578, userId=47102500004, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c5ea1333190f, moduleTitle=LANCET ONCOL：胃癌术后辅助化疗敏感患者的鉴别, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c5ea1333190f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2028873, encodeId=a1cc20288e321, content=<a href='/topic/show?id=b2bd33559be' target=_blank style='color:#2F92EE;'>#化疗敏感#</a>, objectTitle=J Cancer:黄连素增强了乳腺癌的化疗敏感性，并通过剂量编排的AMPK信号通路诱发细胞凋亡, objectType=article, longId=101815, objectId=fc5c1018158d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fc5c1018158d, replyNumber=0, likeNumber=84, createdTime=2017-08-11, rootId=0, userName=ms9651749636653578, userId=47102500004, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fc5c1018158d, moduleTitle=J Cancer:黄连素增强了乳腺癌的化疗敏感性，并通过剂量编排的AMPK信号通路诱发细胞凋亡, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fc5c1018158d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2028872, encodeId=bf8020288e22a, content=<a href='/topic/show?id=b2bd33559be' target=_blank style='color:#2F92EE;'>#化疗敏感#</a>, objectTitle=ASCO2017：微卫星不稳定性转移性结直肠癌预后及化疗敏感性的多中心研究, objectType=article, longId=100859, objectId=e5bb10085956, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e5bb10085956, replyNumber=0, likeNumber=94, createdTime=2018-02-02, rootId=0, userName=ms9651749636653578, userId=47102500004, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e5bb10085956, moduleTitle=ASCO2017：微卫星不稳定性转移性结直肠癌预后及化疗敏感性的多中心研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e5bb10085956)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2028875, encodeId=f77220288e516, content=<a href='/topic/show?id=b2bd33559be' target=_blank style='color:#2F92EE;'>#化疗敏感#</a>, objectTitle=eLife：大肠癌化疗敏感性为何会转变为耐药性？, objectType=article, longId=111843, objectId=a6a511184354, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a6a511184354, replyNumber=0, likeNumber=88, createdTime=2018-01-30, rootId=0, userName=ms9651749636653578, userId=47102500004, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a6a511184354, moduleTitle=eLife：大肠癌化疗敏感性为何会转变为耐药性？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a6a511184354)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2028874, encodeId=096e20288e4b1, content=<a href='/topic/show?id=b2bd33559be' target=_blank style='color:#2F92EE;'>#化疗敏感#</a>, objectTitle=Oncotarget ：EZH2过度表达和伤口渗出液使膀胱癌细胞化疗敏感性变差, objectType=article, longId=105342, objectId=e880105342f5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e880105342f5, replyNumber=0, likeNumber=89, createdTime=2018-06-27, rootId=0, userName=ms9651749636653578, userId=47102500004, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e880105342f5, moduleTitle=Oncotarget ：EZH2过度表达和伤口渗出液使膀胱癌细胞化疗敏感性变差, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e880105342f5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2028871, encodeId=168b20288e156, content=<a href='/topic/show?id=b2bd33559be' target=_blank style='color:#2F92EE;'>#化疗敏感#</a>, objectTitle=Lancet Oncol：贝伐单抗可提高铂化疗敏感的复发性卵巢癌患者生存率, objectType=article, longId=96885, objectId=7d279688506, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7d279688506, replyNumber=0, likeNumber=70, createdTime=2017-07-06, rootId=0, userName=ms9651749636653578, userId=47102500004, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7d279688506, moduleTitle=Lancet Oncol：贝伐单抗可提高铂化疗敏感的复发性卵巢癌患者生存率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7d279688506)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2028869, encodeId=ca0c2028869b7, content=<a href='/topic/show?id=b2bd33559be' target=_blank style='color:#2F92EE;'>#化疗敏感#</a>, objectTitle=Cell Reports：阻断MK2的基因可增加p53突变肿瘤细胞化疗敏感性, objectType=article, longId=26664, objectId=94d1266644f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=94d1266644f, replyNumber=0, likeNumber=95, createdTime=2014-01-07, rootId=0, userName=ms9651749636653578, userId=47102500004, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=94d1266644f, moduleTitle=Cell Reports：阻断MK2的基因可增加p53突变肿瘤细胞化疗敏感性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=94d1266644f)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

化疗敏感

2020-05-29

ms9651749636653578 (审核中...)

前往app查看评论内容

#化疗敏感#

Mol Cancer：新型生物标志物SNORD33可预测三阴性乳腺癌对铂类化疗敏感性

2022-09-12

ms9651749636653578 (审核中...)

前往app查看评论内容

#化疗敏感#

Eur Urol：局部晚期和转移性尿道癌中成纤维细胞生长因子受体3的变异状态与对铂化疗敏感性的差异相关

2020-12-08

ms9651749636653578 (审核中...)

前往app查看评论内容

#化疗敏感#

Blood：IKAROS和CK2调控高危型B-ALL的BCL-XL表达和化疗敏感性

2020-09-30

ms9651749636653578 (审核中...)

前往app查看评论内容

#化疗敏感#

Cell Death Dis：NOD2靶向调节AMPK通路抑制肝癌进展并提高其化疗敏感性

2020-06-11

ms9651749636653578 (审核中...)

前往app查看评论内容

#化疗敏感#

FDA接受葛兰素史克的补充新药申请，将其PARP抑制剂Zejula用作对铂类化疗敏感、晚期卵巢癌患者的一线维持治疗

2020-12-01

ms9651749636653578 (审核中...)

前往app查看评论内容

#化疗敏感#

Prostate：CD4+ T浸润能够减弱前列腺癌的化疗敏感性

2019-06-20

ms9651749636653578 (审核中...)

前往app查看评论内容

#化疗敏感#

BJC：达沙替尼靶向乳腺癌干细胞增加三阴性乳腺癌化疗敏感性

2019-04-02

ms9651749636653578 (审核中...)

前往app查看评论内容

#化疗敏感#

LANCET ONCOL：胃癌术后辅助化疗敏感患者的鉴别

2018-04-14

ms9651749636653578 (审核中...)

前往app查看评论内容

#化疗敏感#

J Cancer:黄连素增强了乳腺癌的化疗敏感性，并通过剂量编排的AMPK信号通路诱发细胞凋亡

2017-08-11

ms9651749636653578 (审核中...)

前往app查看评论内容

#化疗敏感#

ASCO2017：微卫星不稳定性转移性结直肠癌预后及化疗敏感性的多中心研究

2018-02-02

ms9651749636653578 (审核中...)

前往app查看评论内容

#化疗敏感#

eLife：大肠癌化疗敏感性为何会转变为耐药性？

2018-01-30

ms9651749636653578 (审核中...)

前往app查看评论内容

#化疗敏感#

Oncotarget ：EZH2过度表达和伤口渗出液使膀胱癌细胞化疗敏感性变差

2018-06-27

ms9651749636653578 (审核中...)

前往app查看评论内容

#化疗敏感#

Lancet Oncol：贝伐单抗可提高铂化疗敏感的复发性卵巢癌患者生存率

2017-07-06

ms9651749636653578 (审核中...)

前往app查看评论内容

#化疗敏感#

Cell Reports：阻断MK2的基因可增加p53突变肿瘤细胞化疗敏感性

2014-01-07

科室
- - 订阅+
  - 更多科室
工具
服务